Credit Agricole’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.6M | Buy |
122,365
+75,471
| +161% | +$35.2M | 0.14% | 113 |
|
|
2025
Q4 | $21.3M | Sell |
46,894
-15,493
| -25% | -$6.68M | 0.05% | 272 |
|
|
2025
Q3 | $24.4M | Buy |
+62,387
| New | +$26.1M | 0.06% | 215 |
|
|
2025
Q1 | $27M | Sell |
55,672
-41,043
| -42% | -$19.1M | 0.08% | 181 |
|
|
2024
Q4 | $38.9M | Sell |
96,715
-1,792
| -2% | -$831K | 0.11% | 135 |
|
|
2024
Q3 | $45.8M | Buy |
98,507
+18,555
| +23% | +$8.91M | 0.2% | 86 |
|
|
2024
Q2 | $37.5M | Buy |
79,952
+31,359
| +65% | +$13.6M | 0.2% | 94 |
|
|
2024
Q1 | $19.1M | Buy |
48,593
+16,663
| +52% | +$7.04M | 0.21% | 84 |
|
|
2023
Q4 | $13M | Buy |
31,930
+17,899
| +128% | +$6.61M | 0.15% | 120 |
|
|
2023
Q3 | $4.88M | Sell |
14,031
-10,127
| -42% | -$3.54M | 0.08% | 190 |
|
|
2023
Q2 | $8.5M | Sell |
24,158
-572
| -2% | -$193K | 0.15% | 118 |
|
|
2023
Q1 | $7.79M | Sell |
24,730
-2,045
| -8% | -$613K | 0.16% | 113 |
|
|
2022
Q4 | $7.73M | Buy |
26,775
+13,618
| +104% | +$4.15M | 0.16% | 114 |
|
|
2022
Q3 | $3.81M | Buy |
13,157
+10,763
| +450% | +$3.1M | 0.07% | 171 |
|
|
2022
Q2 | $675K | Buy |
2,394
+1,698
| +244% | +$454K | 0.02% | 332 |
|
|
2022
Q1 | $181K | Sell |
696
-50
| -7% | -$11.9K | ﹤0.01% | 428 |
|
|
2021
Q4 | $164K | Hold |
746
| – | – | ﹤0.01% | 430 |
|
|
2021
Q3 | $135K | Sell |
746
-2,895
| -80% | -$565K | ﹤0.01% | 416 |
|
|
2021
Q2 | $734K | Buy |
3,641
+2,891
| +385% | +$605K | 0.02% | 280 |
|
|
2021
Q1 | $161K | Sell |
750
-11,430
| -94% | -$2.51M | ﹤0.01% | 354 |
|
|
2020
Q4 | $2.88M | Buy |
12,180
+12,046
| +8,990% | +$2.76M | 0.09% | 154 |
|
|
2020
Q3 | $36K | Buy |
134
+34
| +34% | +$9.38K | ﹤0.01% | 383 |
|
|
2020
Q2 | $29K | Sell |
100
-100
| -50% | -$27.1K | ﹤0.01% | 353 |
|
|
2020
Q1 | $48K | Hold |
200
| – | – | ﹤0.01% | 320 |
|
|
2019
Q4 | $44K | Hold |
200
| – | – | ﹤0.01% | 322 |
|
|
2019
Q3 | $34K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
|
2019
Q2 | $37K | Hold |
200
| – | – | ﹤0.01% | 387 |
|
|
2019
Q1 | $37K | Buy |
+200
| New | +$36.9K | ﹤0.01% | 392 |
|
|
2017
Q4 | – | Sell |
-61,479
| Closed | -$9.35M | – | 1073 |
|
|
2017
Q3 | $9.35M | Buy |
61,479
+4,546
| +8% | +$684K | 0.03% | 483 |
|
|
2017
Q2 | $7.34M | Sell |
56,933
-9,398
| -14% | -$1.13M | 0.02% | 599 |
|
|
2017
Q1 | $7.25M | Sell |
66,331
-8,078
| -11% | -$711K | 0.02% | 650 |
|
|
2016
Q4 | $5.48M | Buy |
74,409
+13,591
| +22% | +$1.11M | 0.02% | 672 |
|
|
2016
Q3 | $5.3M | Buy |
60,818
+351
| +0.6% | +$33.2K | 0.02% | 672 |
|
|
2016
Q2 | $5.2M | Buy |
60,467
+19,919
| +49% | +$1.72M | 0.02% | 621 |
|
|
2016
Q1 | $3.22M | Buy |
40,548
+857
| +2% | +$77.5K | 0.02% | 671 |
|
|
2015
Q4 | $4.99M | Sell |
39,691
-9,700
| -20% | -$1.17M | 0.02% | 562 |
|
|
2015
Q3 | $5.14M | Sell |
49,391
-21,366
| -30% | -$2.74M | 0.03% | 554 |
|
|
2015
Q2 | $8.74M | Buy |
70,757
+25,805
| +57% | +$3.25M | 0.04% | 443 |
|
|
2015
Q1 | $5.3M | Sell |
44,952
-1,724
| -4% | -$207K | 0.02% | 600 |
|
|
2014
Q4 | $5.63M | Sell |
46,676
-970
| -2% | -$109K | 0.02% | 598 |
|
|
2014
Q3 | $5.35M | Sell |
47,646
-2,476
| -5% | -$236K | 0.02% | 593 |
|
|
2014
Q2 | $4.75M | Sell |
50,122
-7,431
| -13% | -$521K | 0.02% | 646 |
|
|
2014
Q1 | $4.07M | Buy |
57,553
+2,486
| +5% | +$197K | 0.02% | 674 |
|
|
2013
Q4 | $4.09M | Buy |
55,067
+4,510
| +9% | +$314K | 0.02% | 667 |
|
|
2013
Q3 | $3.83M | Buy |
+50,557
| New | +$4.02M | 0.02% | 661 |
|
Other funds holding VRTX
VCM
VPM
Credit Agricole's VRTX Position: Q1 2026 in Review
Credit Agricole increased its Vertex Pharmaceuticals (VRTX) stake by 161% in Q1 2026, buying an estimated $35.2M and bringing the position to 122,365 shares worth $54.6M. The position accounts for 0.14% of the portfolio, ranked #113.
Credit Agricole first reported a position in VRTX in Q3 2013 and has held it in 45 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Credit Agricole held 122,365 shares of Vertex Pharmaceuticals worth $54.6M as of Q1 2026.
- Credit Agricole bought 75,471 Vertex Pharmaceuticals shares in Q1 2026, an estimated $35.2M.
- Vertex Pharmaceuticals made up 0.14% of Credit Agricole's portfolio in Q1 2026, its #113 holding.
- Credit Agricole first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 45 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.